Zydus Lifesciences Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release

08:02 AM

Zydus receives approval from COFEPRIS of Mexico to market Bhava TM (Bevacizumab biosimilar) to treat various cancers

Source: BSE India

View all announcements for Zydus Lifesciences Ltd